|
|
||||||||
Neurology, Vol 48, Issue 5 1238-1243, Copyright © 1997 by American Academy of Neurology
ARTICLES |
C Sobreira, M Hirano, S Shanske, RK Keller, RG Haller, E Davidson, FM Santorelli, AF Miranda, E Bonilla, DS Mojon, AA Barreira, MP King and S DiMauro
H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, Columbia-Presbyterian Medical Center, New York, NY 10032, USA.
Coenzyme Q10 (CoQ10) transfers electrons from complexes I and II of the mitochondrial respiratory chain to complex III. There is one published report of human CoQ10 deficiency describing two sisters with encephalopathy, proximal weakness, myoglobinuria, and lactic acidosis. We report a patient who had delayed motor milestones, proximal weakness, premature exertional fatigue, and episodes of exercise- induced pigmenturia. She also developed partial-complex seizures. Serum creatine kinase was approximately four times the upper limit of normal and venous lactate was mildly elevated. Skeletal muscle biopsy revealed many ragged-red fibers, cytochrome c oxidase-deficient fibers, and excess lipid. In isolated muscle mitochondria, impaired oxygen consumption was corrected by the addition of decylubiquinone. During standardized exercise, ventilatory and circulatory responses were compatible with a defect of oxidation-phosphorylation, which was confirmed by near-infrared spectroscopy analysis. Biochemical analysis of muscle extracts revealed decreased activities of complexes I+II and I+III, while CoQ10 concentration was less than 25% of normal. With a brief course of CoQ10 (150 mg daily), the patient reported subjective improvement. The triad of CNS involvement, recurrent myoglobinuria, and ragged-red fibers should alert clinicians to the possibility of CoQ10 deficiency.
This article has been cited by other articles:
![]() |
C. M. Quinzii, L. C. Lopez, J. Von-Moltke, A. Naini, S. Krishna, M. Schuelke, L. Salviati, P. Navas, S. DiMauro, and M. Hirano Respiratory chain dysfunction and oxidative stress correlate with severity of primary CoQ10 deficiency FASEB J, June 1, 2008; 22(6): 1874 - 1885. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Diomedi-Camassei, S. Di Giandomenico, F. M. Santorelli, G. Caridi, F. Piemonte, G. Montini, G. M. Ghiggeri, L. Murer, L. Barisoni, A. Pastore, et al. COQ2 Nephropathy: A Newly Described Inherited Mitochondriopathy with Primary Renal Involvement J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2773 - 2780. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Gempel, H. Topaloglu, B. Talim, P. Schneiderat, B. G. H. Schoser, V. H. Hans, B. Palmafy, G. Kale, A. Tokatli, C. Quinzii, et al. The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene Brain, August 1, 2007; 130(8): 2037 - 2044. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Lopez-Martin, L. Salviati, E. Trevisson, G. Montini, S. DiMauro, C. Quinzii, M. Hirano, A. Rodriguez-Hernandez, M. D. Cordero, J. A. Sanchez-Alcazar, et al. Missense mutation of the COQ2 gene causes defects of bioenergetics and de novo pyrimidine synthesis Hum. Mol. Genet., May 1, 2007; 16(9): 1091 - 1097. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Horvath, P. Schneiderat, B.G.H. Schoser, K. Gempel, E. Neuen-Jacob, H. Ploger, J. Muller-Hocker, D. E. Pongratz, A. Naini, S. DiMauro, et al. Coenzyme Q10 deficiency and isolated myopathy Neurology, January 24, 2006; 66(2): 253 - 255. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Duncan, S. J.R. Heales, K. Mills, S. Eaton, J. M. Land, and I. P. Hargreaves Determination of Coenzyme Q10 Status in Blood Mononuclear Cells, Skeletal Muscle, and Plasma by HPLC with Di-Propoxy-Coenzyme Q10 as an Internal Standard Clin. Chem., December 1, 2005; 51(12): 2380 - 2382. [Full Text] [PDF] |
||||
![]() |
C. Lamperti, A. B. Naini, V. Lucchini, A. Prelle, N. Bresolin, M. Moggio, M. Sciacco, P. Kaufmann, and S. DiMauro Muscle Coenzyme Q10 Level in Statin-Related Myopathy Arch Neurol, November 1, 2005; 62(11): 1709 - 1712. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Salviati, S. Sacconi, L. Murer, G. Zacchello, L. Franceschini, A. M. Laverda, G. Basso, C. Quinzii, C. Angelini, M. Hirano, et al. Infantile encephalomyopathy and nephropathy with CoQ10 deficiency: A CoQ10-responsive condition Neurology, August 23, 2005; 65(4): 606 - 608. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Quinzii, A. G. Kattah, A. Naini, H. O. Akman, V. K. Mootha, S. DiMauro, and M. Hirano Coenzyme Q deficiency and cerebellar ataxia associated with an aprataxin mutation Neurology, February 8, 2005; 64(3): 539 - 541. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. R. Lalani, G. D. Vladutiu, K. Plunkett, T. E. Lotze, A. M. Adesina, and F. Scaglia Isolated Mitochondrial Myopathy Associated With Muscle Coenzyme Q10 Deficiency Arch Neurol, February 1, 2005; 62(2): 317 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Zeviani and S. Di Donato Mitochondrial disorders Brain, October 1, 2004; 127(10): 2153 - 2172. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Aure, J. F. Benoist, H. O. de Baulny, N. B. Romero, O. Rigal, and A. Lombes Progression despite replacement of a myopathic form of coenzyme Q10 defect Neurology, August 24, 2004; 63(4): 727 - 729. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Rundek, A. Naini, R. Sacco, K. Coates, and S. DiMauro Atorvastatin Decreases the Coenzyme Q10 Level in the Blood of Patients at Risk for Cardiovascular Disease and Stroke Arch Neurol, June 1, 2004; 61(6): 889 - 892. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Gironi, C. Lamperti, R. Nemni, M. Moggio, G. Comi, F. R. Guerini, P. Ferrante, N. Canal, A. Naini, N. Bresolin, et al. Late-onset cerebellar ataxia with hypogonadism and muscle coenzyme Q10 deficiency Neurology, March 9, 2004; 62(5): 818 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Golomb, M. H. Criqui, H. White, and J. E. Dimsdale Conceptual Foundations of the UCSD Statin Study: A Randomized Controlled Trial Assessing the Impact of Statins on Cognition, Behavior, and Biochemistry Arch Intern Med, January 26, 2004; 164(2): 153 - 162. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lamperti, A. Naini, M. Hirano, D.C. De Vivo, E. Bertini, S. Servidei, M. Valeriani, D. Lynch, B. Banwell, M. Berg, et al. Cerebellar ataxia and coenzyme Q10 deficiency Neurology, April 8, 2003; 60(7): 1206 - 1208. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Taivassalo, T. Dysgaard Jensen, N. Kennaway, S. DiMauro, J. Vissing, and R. G. Haller The spectrum of exercise tolerance in mitochondrial myopathies: a study of 40 patients Brain, February 1, 2003; 126(2): 413 - 423. [Abstract] [Full Text] [PDF] |
||||
![]() |
R Horvath, C Scharfe, M Hoeltzenbein, B H Do, C Schroder, R Warzok, S Vogelgesang, H Lochmuller, J Muller-Hocker, K D Gerbitz, et al. Childhood onset mitochondrial myopathy and lactic acidosis caused by a stop mutation in the mitochondrial cytochrome c oxidase III gene J. Med. Genet., November 1, 2002; 39(11): 812 - 816. [Full Text] [PDF] |
||||
![]() |
S. Di Giovanni, M. Mirabella, A. Spinazzola, P. Crociani, G. Silvestri, A. Broccolini, P. Tonali, S. Di Mauro, and S. Servidei Coenzyme Q10 reverses pathological phenotype and reduces apoptosis in familial CoQ10 deficiency Neurology, August 14, 2001; 57(3): 515 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Musumeci, A. Naini, A. E. Slonim, N. Skavin, G. L. Hadjigeorgiou, N. Krawiecki, B. M. Weissman, C.-Y. Tsao, J. R. Mendell, S. Shanske, et al. Familial cerebellar ataxia with muscle coenzyme Q10 deficiency Neurology, April 10, 2001; 56(7): 849 - 855. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Karadimas, P. Greenstein, C. M. Sue, J. T. Joseph, K. Tanji, R. G. Haller, T. Taivassalo, M. M. Davidson, S. Shanske, E. Bonilla, et al. Recurrent myoglobinuria due to a nonsense mutation in the COX I gene of mitochondrial DNA Neurology, September 12, 2000; 55(5): 644 - 649. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Jonassen and C. F. Clarke Isolation and Functional Expression of Human COQ3, a Gene Encoding a Methyltransferase Required for Ubiquinone Biosynthesis J. Biol. Chem., April 21, 2000; 275(17): 12381 - 12387. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Wariar, J. N. Gaffke, R. G. Haller, and L. A. Bertocci A modular NIRS system for clinical measurement of impaired skeletal muscle oxygenation J Appl Physiol, January 1, 2000; 88(1): 315 - 325. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Artuch, M-A. Vilaseca, J. Moreno, N. Lambruschini, F. J Cambra, and J. Campistol Decreased serum ubiquinone-10 concentrations in phenylketonuria Am. J. Clinical Nutrition, November 1, 1999; 70(5): 892 - 895. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |